Totally biological composite aortic stentless valved conduit for aortic root replacement: 10-year experience
2011

Long-term results of a biological aortic valved conduit for heart surgery

Sample size: 67 publication Evidence: moderate

Author Information

Author(s): Galiñanes Manuel, Meduoye Ayo, Ferreira Ignacio, Sosnowski Andrzej

Primary Institution: The Glenfield Hospital, Leicester, UK

Hypothesis

The No-React® BioConduit will provide better long-term outcomes compared to traditional synthetic grafts in aortic root replacement.

Conclusion

The No-React® BioConduit composite stentless aortic valved conduit provides excellent long-term clinical results for aortic root replacement with few prosthesis-related complications in the first post-operative decade.

Supporting Evidence

  • More than 50% of survivors were in NYHA I/II after 7.1 years.
  • 88% of patients were free from valved-conduit related complications leading to mortality.
  • Post-operative echocardiography showed no evidence of stenosis, dilatation, calcification, or thrombosis.

Takeaway

Doctors used a special type of heart valve made from animal tissue in 67 patients, and it worked really well for a long time without causing many problems.

Methodology

Patients received the No-React® BioConduit graft during the Bentall procedure, and their outcomes were followed for an average of 7.1 years.

Limitations

The study is retrospective and conducted at a single center, which may limit the generalizability of the results.

Participant Demographics

60% male, mean age 67.9 years, with a range from 34.1 to 83.8 years.

Statistical Information

Confidence Interval

95% CI 5.5-7.7 for mean survival time.

Digital Object Identifier (DOI)

10.1186/1749-8090-6-86

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication